This event has been canceled due to the current outbreak of COVID-19.
This mini-symposium will bring together scientists interested in understanding the impact of cancer therapies on a molecular level in the cell, on the tumor and for the patient. It aims to provide an opportunity to learn about the changes cancer drugs confer on the genome, transcriptome and proteome and to learn on target-engagement and toxicity.
Päivi Östling, Karolinska Institutet/SciLifeLab
Ulrika Warpman, Karolinska Institutet/SciLifeLab
Anna Dimberg, Uppsala University/SciLifeLab
Registration is not available.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.